Stanley C. Erck, CEO and President at NOVAVAX INC (NVAX), bought 2,072 shares at $4.38 ($9K) on 2016-01-31, disclosed to the SEC on 2016-02-01.
Open-market purchase of $9k NVAX by CEO and President. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| MXCT | SELL | 2024-10-02 | $358K | — | Filing → |
| MXCT | SELL | 2024-09-05 | $383K | — | Filing → |
| NVAX | SELL | 2021-10-05 | $16.6M | — | Filing → |